Aug 22, 2025 • Zacks Commentary
BULLISH
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
Aug 22, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
Aug 21, 2025 • Zacks Commentary
NEUTRAL
Elevance Shoots for the Stars But Lands at 3.5: $375M Bonus Gone?
Federal judge dismisses ELV's lawsuit challenging Medicare Advantage star ratings, leading to a $375M bonus loss tied to its star score.
Aug 20, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
CNC vs. HUM: Which Managed-Care Stock is a Smarter Investment?
Humana's strong Medicare Advantage growth and higher ROE give it an edge over Centene, which faces earnings pressure and OBBB Act headwinds.
Aug 20, 2025 • Zacks Commentary
BULLISH
UnitedHealth's Push Into Home Health: A New Growth Chapter?
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
CORRECTION - Bringing Advanced Vascular Diagnostics to the Western US with the SmartVascular Dx™ Test
IRVINE, Calif., Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- MorningStar Laboratories, LLC., ( "MSL" or "the Company" ) , a leading developer of precision diagnostic tests that addresses unmet clinical needs, announced today corrections to the second paragraph of its press release under the same headline ...